| Website | sirigen.com |
| Category | BioTech |
| Phone | +44(0)203 176 0444 |
| Employees |
| LetsCram | 1/09 |
| Unattributed, 11/10 Seraphim Capital Oxford Capital Partners IQ Capital Partners YFM Private Equity | $3.83M |
Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces.
Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.